title: The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP).
abstract: The Product Quality Research Institute (PQRI) is a non-profit consortium of organizations working together to generate and share timely, relevant, and impactful information that advances drug product quality and development. The collaborative activities of PQRI participants have, in the case of orally inhaled and nasal drug products (OINDPs), resulted in comprehensive and widely-accepted recommendations for leachables assessments to help ensure patient safety with respect to this class of packaged drug products. These recommendations, which include scientifically justified safety thresholds for leachables, represent a significant milestone towards establishing standardized approaches for safety qualification of leachables in OINDP. To build on the success of the OINDP effort, PQRI's Parenteral and Ophthalmic Drug Products (PODP) Leachables and Extractables Working Group was formed to extrapolate the OINDP threshold concepts and best practice recommendations to other dosage forms with high concern for interaction with packaging/delivery systems. This article considers the general aspects of leachables and their safety assessment, introduces the PODP Work Plan and initial study Protocol, discusses the laboratory studies being conducted by the PODP Chemistry Team, outlines the strategy being developed by the PODP Toxicology Team for the safety qualification of PODP leachables, and considers the issues associated with application of the safety thresholds, particularly with respect to large-volume parenterals. Lastly, the unique leachables issues associated with biologics are described.
  The Product Quality Research Institute (PQRI) is a non-profit consortium involving industry organizations, academia, and regulatory agencies that together provide recommendations in support of regulatory guidance to advance drug product quality. The collaborative activities of the PQRI Orally Inhaled and Nasal Drug Products Leachables and Extractables Working Group resulted in a systematic and science-based approach to identify and qualify leachables, including the concept of safety thresholds. Concepts from this widely accepted approach, formally publicized in 2006, are being extrapolated to parenteral and ophthalmic drug products. This article provides an overview of extractables and leachables in drug products and biologics and discusses the PQRI Work Plan and Protocols developed by the PQRI Parenteral and Ophthalmic Drug Products Leachables and Extractables Working Group.
authors.affiliation: West Pharmaceutical Services, Exton PA, USA.
authors.forename: Diane
authors.initials: D
authors.lastname: Paskiet
authors.forename: Dennis
authors.initials: D
authors.lastname: Jenke
authors.forename: Douglas
authors.initials: D
authors.lastname: Ball
authors.forename: Christopher
authors.initials: C
authors.lastname: Houston
authors.forename: Daniel L
authors.initials: DL
authors.lastname: Norwood
authors.forename: Ingrid
authors.initials: I
authors.lastname: Markovic
mesh_terms: D000047:Academies and Institutes; D004340:Drug Contamination; D004345:Drug Industry; D004349:Drug Packaging; D006801:Humans; D010288:Parenteral Nutrition; D004364:Pharmaceutical Preparations / Q000008:administration & dosage
chemical_list: D004364:Pharmaceutical Preparations
keywords: Best practice recommendations; Biologic concerns; Extractables; Leachables; Ophthalmic containers; PQRI; Parenteral and ophthalmic drug products; Parenteral packaging; Safety assessment; Safety qualification thresholds